The ratio of maternal angiogenic proteins including soluble Fms‐like tyrosine kinase 1(sFlt‐1) and placental growth factor (PlGF) provides a measure of anti‐angiogenesis, and is measured in the mid‐to‐late 2nd trimester to predict preeclampsia.8, 9. Here, PGF is linked to preeclampsia.